Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CATX | Lantheus Alpha Therapy, LLC | 10% Owner | 09/01/2026 | Verkauf | 3.12 | 35,769 | 111,574 | Form 4 |
| NEGG | Chang Fred Faching | Director | 09/01/2026 | Verkauf | 15.87 | 3,582 | 56,857 | Form 4 |
| LPA | Marquina Javier | Director | 09/01/2026 | Verkauf | 3.09 | 1,800 | 5,562 | Form 4 |
| ANTX | Williams Sarah Joanne | Principal Accounting Officer | 09/01/2026 | Verkauf | 5.53 | 272 | 1,504 | Form 4 |
| INDI | Wu Naixi | Chief Financial Officer | 09/01/2026 | Verkauf | 3.56 | 6,000 | 21,346 | Form 4 |
| ELF | Franks Joshua Allen | SVP, Operations | 09/01/2026 | Verkauf | 110.00 | 5,512 | 606,320 | Form 4 |
| ZM | Yuan Eric S. | Chief Executive Officer | 09/01/2026 | Verkauf | 95.89 | 1,373 | 131,654 | Form 4 |
| ZM | Yuan Eric S. | Chief Executive Officer | 09/01/2026 | Verkauf | 95.27 | 10,727 | 1,021,957 | Form 4 |
| YELP | Amara Carmen | Chief People Officer | 09/01/2026 | Verkauf | 22.14 | 500 | 11,070 | Form 4 |
| XMTR | Altschuler Randolph | Director | 09/01/2026 | Verkauf | 92.09 | 481 | 44,293 | Form 4 |
| XMTR | Altschuler Randolph | Director | 09/01/2026 | Verkauf | 91.03 | 4,912 | 447,122 | Form 4 |
| XMTR | Altschuler Randolph | Director | 09/01/2026 | Verkauf | 90.47 | 4,607 | 416,802 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 204.92 | 100 | 20,492 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 204.28 | 1,900 | 388,130 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 203.40 | 6,199 | 1,260,893 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 202.40 | 1,901 | 384,755 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 201.40 | 4,100 | 825,747 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 200.14 | 4,800 | 960,653 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 199.01 | 35,196 | 7,004,310 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 198.29 | 36,729 | 7,282,946 | Form 4 |
| WDAY | Duffield David A | 10% Owner | 09/01/2026 | Verkauf | 197.38 | 4,036 | 796,618 | Form 4 |
| DIS | Woodford Brent | EVP, Control, Fin Plan & Tax | 09/01/2026 | Verkauf | 107.13 | 3,618 | 387,596 | Form 4 |
| WWW | Boromisa Jeffrey M | Director | 09/01/2026 | Verkauf | 19.58 | 25,000 | 489,500 | Form 4 |
| WLFC | Willis Austin Chandler | President and CEO | 09/01/2026 | Verkauf | 53.90 | 15,000 | 808,565 | Form 4 |
| WEX | Smith Melissa D | CEO and President | 09/01/2026 | Verkauf | 191.11 | 11,109 | 2,123,041 | Form 4 |
| WEX | Smith Melissa D | CEO and President | 09/01/2026 | Verkauf | 189.87 | 7,575 | 1,438,265 | Form 4 |
| WEX | Smith Melissa D | CEO and President | 09/01/2026 | Verkauf | 189.12 | 9,245 | 1,748,414 | Form 4 |
| WEX | Smith Melissa D | CEO and President | 09/01/2026 | Verkauf | 186.48 | 180 | 33,566 | Form 4 |
| WAB | Santana Rafael | President and CEO | 09/01/2026 | Verkauf | 281.74 | 118 | 33,246 | Form 4 |
| WAB | Santana Rafael | President and CEO | 09/01/2026 | Verkauf | 279.87 | 590 | 165,124 | Form 4 |
| WAB | Santana Rafael | President and CEO | 09/01/2026 | Verkauf | 280.86 | 194 | 54,487 | Form 4 |
| VICR | Davies Philip D | Corp. VP-Global Sales & Mktg. | 09/01/2026 | Verkauf | 184.85 | 100 | 18,485 | Form 4 |
| VICR | Davies Philip D | Corp. VP-Global Sales & Mktg. | 09/01/2026 | Verkauf | 178.66 | 700 | 125,062 | Form 4 |
| VICR | Davies Philip D | Corp. VP-Global Sales & Mktg. | 09/01/2026 | Verkauf | 177.63 | 1,100 | 195,394 | Form 4 |
| VICR | Davies Philip D | Corp. VP-Global Sales & Mktg. | 09/01/2026 | Verkauf | 176.59 | 1,173 | 207,143 | Form 4 |
| VSAT | Stenbit John P | Director | 09/01/2026 | Verkauf | 66.75 | 705 | 47,059 | Form 4 |
| VSAT | Palmer Benjamin Edward | SVP, Pres Commercial | 09/01/2026 | Verkauf | 66.75 | 2,000 | 133,500 | Form 4 |
| VCYT | Bhanji Muna | Director | 09/01/2026 | Verkauf | 42.97 | 1,864 | 80,096 | Form 4 |
| URBN | Egan Mary | Director | 09/01/2026 | Verkauf | 78.48 | 650 | 51,012 | Form 4 |
| ULS | Scanlon Jennifer F. | President and CEO | 09/01/2026 | Verkauf | 74.43 | 2,005 | 149,225 | Form 4 |
| ULS | Scanlon Jennifer F. | President and CEO | 09/01/2026 | Verkauf | 73.52 | 10,495 | 771,575 | Form 4 |
| TRU | Skinner Todd C. | President, International | 09/01/2026 | Verkauf | 84.42 | 1,000 | 84,420 | Form 4 |
| TRU | Chaouki Steven M | President, US Markets | 09/01/2026 | Verkauf | 84.42 | 1,000 | 84,420 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 64.63 | 1,000 | 64,630 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 63.80 | 5,900 | 376,420 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 62.64 | 10,900 | 682,776 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 62.12 | 13,046 | 810,418 | Form 4 |
| TEM | Doudna Jennifer A | Director | 09/01/2026 | Verkauf | 65.55 | 676 | 44,312 | Form 4 |
| TEM | Epstein David R | Director | 09/01/2026 | Verkauf | 65.55 | 250 | 16,388 | Form 4 |
| TARS | Lin Elizabeth Yeu | Chief Medical Officer | 09/01/2026 | Verkauf | 73.86 | 4,601 | 339,830 | Form 4 |
| TRGP | Chung Paul W | Director | 09/01/2026 | Verkauf | 297.00 | 816 | 242,352 | Form 4 |
| TRGP | Chung Paul W | Director | 09/01/2026 | Verkauf | 295.38 | 1,000 | 295,381 | Form 4 |
| TNGX | Crystal Adam | President, R&D | 09/01/2026 | Verkauf | 22.37 | 27,000 | 603,909 | Form 4 |
| SYM | Kane Charles | Director | 09/01/2026 | Verkauf | 39.00 | 2,000 | 78,000 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 09/01/2026 | Verkauf | 31.06 | 1,600 | 49,691 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 09/01/2026 | Verkauf | 30.51 | 3,945 | 120,370 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 89.38 | 400 | 35,752 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 88.17 | 6,206 | 547,183 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 87.20 | 16,548 | 1,442,986 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 86.40 | 4,845 | 418,608 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).